![(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfanyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol](https://img.chemicalbook.com/CAS2/GIF/153004-31-0.gif)
M5242135
(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfanyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol , 90% , 153004-31-0
CAS NO.：153004-31-0
Empirical Formula: C32H47F5O2S
Molecular Weight: 590.77
MDL number: MFCD21609269
EINECS: 206-141-6
| Pack Size | Price | Stock | Quantity |
| 1g | RMB2608.00 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Boiling point: | 622.1±55.0 °C(Predicted) |
| Density | 1.159 |
| storage temp. | 2-8°C |
| pka | 10.27±0.70(Predicted) |
| InChIKey | BVAUHWMMAVAPFK-FUYZNXCTNA-N |
| SMILES | C1(O)=CC2=C(C=C1)[C@]1([H])[C@]([H])([C@@]3([H])[C@@](CC1)(C)[C@@H](O)CC3)[C@H](CCCCCCCCCSCCCC(F)(F)C(F)(F)F)C2 |&1:7,9,11,13,17,21,r| |
| EPA Substance Registry System | S-Deoxo fulvestrant (153004-31-0) |
Description and Uses
S-Deoxo Fulvestrant ((7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol) is an intermediate of fulvestrant, a breast cancer medication/drug.
Safety
| Symbol(GHS) |   GHS08,GHS09 |
| Signal word | Danger |
| Hazard statements | H410-H360-H362 |
| Precautionary statements | P273-P391-P501-P201-P260-P263-P264-P270-P308+P313 |